BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35229101)

  • 1. The Paget's disease of bone risk gene PML is a negative regulator of osteoclast differentiation and bone resorption.
    Wani S; Daroszewska A; Salter DM; van 't Hof RJ; Ralston SH; Albagha OME
    Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35229101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aged G Protein-Coupled Receptor Kinase 3 (Grk3)-Deficient Mice Exhibit Enhanced Osteoclastogenesis and Develop Bone Lesions Analogous to Human Paget's Disease of Bone.
    Rabjohns EM; Rampersad RR; Ghosh A; Hurst K; Eudy AM; Brozowski JM; Lee HH; Ren Y; Mirando A; Gladman J; Bowser JL; Berg K; Wani S; Ralston SH; Hilton MJ; Tarrant TK
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice.
    Daroszewska A; van 't Hof RJ; Rojas JA; Layfield R; Landao-Basonga E; Rose L; Rose K; Ralston SH
    Hum Mol Genet; 2011 Jul; 20(14):2734-44. PubMed ID: 21515589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted sequencing of the Paget's disease associated 14q32 locus identifies several missense coding variants in RIN3 that predispose to Paget's disease of bone.
    Vallet M; Soares DC; Wani S; Sophocleous A; Warner J; Salter DM; Ralston SH; Albagha OM
    Hum Mol Genet; 2015 Jun; 24(11):3286-95. PubMed ID: 25701875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A FKBP5 mutation is associated with Paget's disease of bone and enhances osteoclastogenesis.
    Lu B; Jiao Y; Wang Y; Dong J; Wei M; Cui B; Sun Y; Wang L; Zhang B; Chen Z; Zhao Y
    Exp Mol Med; 2017 May; 49(5):e336. PubMed ID: 28524179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclast signaling-targeting miR-146a-3p and miR-155-5p are downregulated in Paget's disease of bone.
    Stephens E; Roy M; Bisson M; Nguyen HD; Scott MS; Boire G; Bouchard L; Roux S
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165852. PubMed ID: 32485219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone.
    Sambandam Y; Sundaram K; Saigusa T; Balasubramanian S; Reddy SV
    Bone; 2017 Aug; 101():236-244. PubMed ID: 28506889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p62/sequestosome 1 deficiency accelerates osteoclastogenesis
    Zach F; Polzer F; Mueller A; Gessner A
    J Biol Chem; 2018 Jun; 293(24):9530-9541. PubMed ID: 29555685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optineurin Negatively Regulates Osteoclast Differentiation by Modulating NF-κB and Interferon Signaling: Implications for Paget's Disease.
    Obaid R; Wani SE; Azfer A; Hurd T; Jones R; Cohen P; Ralston SH; Albagha OME
    Cell Rep; 2015 Nov; 13(6):1096-1102. PubMed ID: 26527009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic regulatory mechanisms in human osteoclasts suggest a role for the STMP1 and DCSTAMP genes in Paget's disease of bone.
    Mullin BH; Zhu K; Brown SJ; Mullin S; Tickner J; Pavlos NJ; Dudbridge F; Xu J; Walsh JP; Wilson SG
    Sci Rep; 2019 Jan; 9(1):1052. PubMed ID: 30705363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget's disease.
    Wong SW; Huang BW; Hu X; Ho Kim E; Kolb JP; Padilla RJ; Xue P; Wang L; Oguin TH; Miguez PA; Tseng HC; Ko CC; Martinez J
    Cell Death Differ; 2020 Jan; 27(1):71-84. PubMed ID: 31076632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paget's Disease of Bone.
    Gennari L; Rendina D; Falchetti A; Merlotti D
    Calcif Tissue Int; 2019 May; 104(5):483-500. PubMed ID: 30671590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
    Hiruma Y; Kurihara N; Subler MA; Zhou H; Boykin CS; Zhang H; Ishizuka S; Dempster DW; Roodman GD; Windle JJ
    Hum Mol Genet; 2008 Dec; 17(23):3708-19. PubMed ID: 18765443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
    Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
    J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic analysis of Paget's disease of bone identifies differentially methylated loci that predict disease status.
    Diboun I; Wani S; Ralston SH; Albagha OM
    Elife; 2021 Apr; 10():. PubMed ID: 33929316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Inactivation of Rin3 Increases Trabecular Bone Mass by Reducing Bone Resorption and Favouring Bone Formation.
    Vallet M; Sophocleous A; Törnqvist AE; Azfer A; Hof RV; Albagha OM; Ralston SH
    Calcif Tissue Int; 2021 Jul; 109(1):92-102. PubMed ID: 33725152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Loss of Profilin 1 Causes Early Onset Paget's Disease of Bone.
    Scotto di Carlo F; Pazzaglia L; Esposito T; Gianfrancesco F
    J Bone Miner Res; 2020 Aug; 35(8):1387-1398. PubMed ID: 31991009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optineurin regulates osteoblast function in an age-dependent fashion in a mouse model of Paget's disease of bone.
    Hu X; Foster BL; Zhao B; Tseng HC; Wu YC; Ko CC
    Bone; 2023 Dec; 177():116929. PubMed ID: 37802379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone.
    Albagha OM; Wani SE; Visconti MR; Alonso N; Goodman K; Brandi ML; Cundy T; Chung PY; Dargie R; Devogelaer JP; Falchetti A; Fraser WD; Gennari L; Gianfrancesco F; Hooper MJ; Van Hul W; Isaia G; Nicholson GC; Nuti R; Papapoulos S; Montes Jdel P; Ratajczak T; Rea SL; Rendina D; Gonzalez-Sarmiento R; Di Stefano M; Ward LC; Walsh JP; Ralston SH;
    Nat Genet; 2011 May; 43(7):685-9. PubMed ID: 21623375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
    Neale SD; Smith R; Wass JA; Athanasou NA
    Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.